MedPath

Chemotherapy in Japanese advanced lung cancer patients: a descriptive study using database

Not Applicable
Conditions
Advanced lung cancer
Registration Number
JPRN-UMIN000016418
Lead Sponsor
Department of Healthcare Epidemiology, Graduate School of Medicine and Public Health, Kyoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

-18> -Received thoracic radiotherapy within 8 days of 1st chemotherapy -If they had any previously diagnosed cancers -Did not survive at least 30 days past diagnosis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proportion of each chemotherapy regimen.
Secondary Outcome Measures
NameTimeMethod
Overall survival, costs, adverse events of each chemotherapy regimen.
© Copyright 2025. All Rights Reserved by MedPath